Prognostic significance of fascin and Wilm’s tumor 1 (WT1) in oral squamous cell carcinomas – case control study

2018 ◽  
Vol 64 (2) ◽  
pp. 1187-1202
Author(s):  
Samah El-Meadawy ◽  
Naglaa Salama ◽  
Lobna Radwan ◽  
Mahmoud El-sherbiny
2011 ◽  
Author(s):  
Michelle R. Iannacone ◽  
Heather G. Stockwell ◽  
Wei Wang ◽  
Kathleen O'Rourke ◽  
Vernon K. Sondak ◽  
...  

BMC Cancer ◽  
2012 ◽  
Vol 12 (1) ◽  
Author(s):  
Michelle R Iannacone ◽  
Wei Wang ◽  
Heather G Stockwell ◽  
Kathleen O’Rourke ◽  
Anna R Giuliano ◽  
...  

BMJ ◽  
2010 ◽  
Vol 341 (jul08 1) ◽  
pp. c2986-c2986 ◽  
Author(s):  
M. R. Karagas ◽  
T. Waterboer ◽  
Z. Li ◽  
H. H. Nelson ◽  
K. M. Michael ◽  
...  

2010 ◽  
Vol 2010 ◽  
pp. 1-8 ◽  
Author(s):  
Neda Ahmadi ◽  
Radoslav Goldman ◽  
Françoise Seillier-Moiseiwitsch ◽  
Anne-Michelle Noone ◽  
Ourania Kosti ◽  
...  

We evaluated the chemopreventive effect of nonsteroidal anti-inflammatory drug (NSAID) use in head and neck squamous cell carcinomas (HNSCC) by conducting a case-control study based on the administration of a standardized questionnaire to 71 incident HNSCC cases and same number of healthy controls. NSAID use was associated with a 75% reduction in risk of developing HNSCC. A significant risk reduction was noted in association with frequency of NSAID use. Restricting the analysis to aspirin users revealed a significant 90% reduction in risk of developing HNSCC. This study provides evidence for a significant reduction in the risk of developing HNSCC in users of NSAIDs, and specifically aspirin users.


Sign in / Sign up

Export Citation Format

Share Document